Unmanipulated, related, haploidentical transplantation can achieve comparable outcomes to identical sibling transplantation for pediatric patients with high-risk acute leukemia

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-11001831

Enrollment

Unknown

Registered

2011-12-20

Start date

2000-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignancies

Interventions

1:related haplo-HSCT

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. 1-18 yr; 2. patients who received HSCT between June of 2000 and December of 2010; 3. patients with high risk acute leukemia; 4. Consent form signed.

Exclusion criteria

Exclusion criteria: 1. less than 1 yr or more than 18 yr; 2. low risk or intermediate acute leukemia; 3. uncontrolled infections or organ dysfunction; 4. unconsentness

Design outcomes

Primary

Measure	Time frame
LFS;	—

Secondary

Measure	Time frame
engraftment;GVHD incidence;incidence of relaps;	—

Contacts

Public ContactXiaojun Huang

xjhrm@medmail.com.cn+86 10 88326002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026